References
- ZieglerS, SperrWR, KnoblP, LehrS, WeltermannA, JagerU. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis. Thromb Res 2005;115:59–64.
- De StefanoV, SoraF, RossiE, et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005;3:1985–1992.
- FalangaA, RicklesFR. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Best Pract Res Clin Haematol 2003;16:463–482.
- TallmanMS, LefebvreP, BaineRM, et al. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. J Thromb Haemost 2004;2:1341–1350.
- Di NotoR, SchiavoneEM, FerraraF, et al. All trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid blast cells. Br J Haematol 1996;88:247–255.
- BrecciaM, AvvisatiG, LatagliataR, et al. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia 2007;21:79–83.
- MontesinosP, de la SernaJ, VellengaE, et al. Incidence and risk factors for thrombosis in patients with acute promyelocytic leukemia. Experience of the PETHEMA LPA96 and LPA99 Protocols. Blood 2006;108(Suppl. 1): Abstract 1503.
- MontesinosP, BerguaJM, VellengaE, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-transretinoic acid and anthracycline chemotherapy: characteristics, outcome and prognostic factors. Blood 2009;113:775–783.
- ChillarRK, PaladuguRR. Case report: hepatic vein thrombosis (acute Budd–Chiari syndrome) in acute leukemia. Am J Med Sci 1981;282:153–156.
- RiccioJA, ColleyAT, CeraPJ. Hepatic vein thrombosis (Budd–Chiari syndrome) in the microgranular variant of acute promyelocytic leukemia. Am J Clin Pathol 1989;92:366–371.
- AmitranoL, GuardascioneMA, SchiavoneEM, et al. Hepatic vein thrombosis leading to fulminant hepatic failure in a case of acute non-promyelocytic myelogenous leukemia. Blood Coagul fibrinolysis 2006;17:59–61.
- TorromeoC, LatagliataR, AvvisatiG, et al. Intraventricular thrombosis during all trans retinoic acid treatment in acute promyeloctic leukemia. Leukemia 2001;15:1311–1313.
- Di NotoR, Lo PardoC, SchiavoneEM, et al. All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma 1996;21:201–209.
- RodeghieroF, AvvisatiG, CastamanG, et al. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. Blood 1990;75:2112–2117.
- FalangaA, RicklesFR. Management of thrombohemorrhagic syndromes (THS) in hematologic malignancies. Hematology Am Soc Hematol Educ Program 2007:165–171.